APA

Benkerrou M., Jais J. P., Leblond V., Durandy A., Sutton L., Bordigoni P., Garnier J. L., Le Bidois J., Le Deist F., Blanche S. & Fischer A. (19981130). Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. : Blood.

Chicago

Benkerrou M, Jais J P, Leblond V, Durandy A, Sutton L, Bordigoni P, Garnier J L, Le Bidois J, Le Deist F, Blanche S and Fischer A. 19981130. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. : Blood.

Harvard

Benkerrou M., Jais J. P., Leblond V., Durandy A., Sutton L., Bordigoni P., Garnier J. L., Le Bidois J., Le Deist F., Blanche S. and Fischer A. (19981130). Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. : Blood.

MLA

Benkerrou M, Jais J P, Leblond V, Durandy A, Sutton L, Bordigoni P, Garnier J L, Le Bidois J, Le Deist F, Blanche S and Fischer A. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. : Blood. 19981130.